Esperion Therapeutics | 8-K: Current report
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
Esperion Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Two Seas Capital LP(3.3%),Two Seas Capital GP LLC(3.3%), etc.
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.64%)
Esperion Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.3%)
Esperion Therapeutics | 10-Q: Q3 2024 Earnings Report
Esperion Therapeutics | 8-K: Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.64%)
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.64%)
Esperion Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.3%)
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
Esperion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(1.7%),Millennium Group Management LLC(1.7%), etc.
Esperion Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Koenig Sheldon L.
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
Esperion Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Esperion Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Esperion Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Esperion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warren Eric
No Data